The Billion-Dollar Signature; Data, Methods, and Sources

Sources: the June 2025 option grant, its forfeiture conditions, the abandonment of the separation and the committee's stated reasoning per WBD's annual proxy filed 30 April 2026 (accession 0001437107-26-000046). The January 2026 grants per the FY2025 Form 10-K. The tax reimbursement agreement of 10 March 2026, the $886.8 million package total, the decline-over-time language, the $7 billion reverse termination fee, the ticking consideration of $0.25 a share per ninety days and the interim operating covenants per the merger proxy of 26 March 2026 (accession 0001193125-26-125075). Unaffected share price of $12.54 and the $31.00 offer per the merger proxy; the roughly $46 billion of value added is this newsletter's arithmetic on that pair. The option hurdles of $12.19, $15.24 and $16.76 and the dates on which they were certified are per the annual proxy: the first cleared in late July 2025 on standalone trading, the other two after the bid became public on 11 September 2025, when the shares rose 28.9 percent. Paramount's Delaware complaint of January 2026 alleging breach of fiduciary duty, filed while the board was preferring the Netflix structure, is per WBD's FY2025 Form 10-K, Item 3. The characterisation of ordinary practice rests on ISS's US equity compensation plans guidance, which treats vesting linked to a transaction's approval "rather than its consummation" as a liberal change-in-control definition capable of producing "windfall compensation without the occurrence of an actual change in control"; on Meridian's 2023 change-in-control study, in which 91 percent of time-based awards at 500 large US companies vest only on a double trigger; and on Compensation Advisory Partners' finding that essentially all disclosed merger retention and transaction awards vest at closing or later. No survey measures signing-triggered vesting, because it is not a category anyone tracks; no comparable public case was found, which is a failure to find rather than proof of absence. Operating effects of blocked deals and the cash-versus-stock revaluation result per Malmendier, Opp and Saidi, Journal of Financial Economics 119(1), 2016, on 236 unsuccessful bids 1980 to 2008. Anthem and Cigna litigation per contemporaneous reporting. ISS positions on this package per Variety and TheWrap, April 2026. Reporting on the Ellison family's relationship with the administration is widely published and is not established by any filing; the suggestion that the board read regulatory risk through it is stated here as a possibility only, and the pending challenge is a state action rather than a federal one. The amendment language is from the letter agreement of 7 November 2025 filed as Exhibit 10.1 to the Form 8-K of 13 November 2025, read in full, together with the option grant agreement and the employment agreement filed with the Form 8-K of 16 June 2025; the operative words are that entry into a qualifying change of control agreement "shall be sufficient to lift the Spinoff Restriction," after which the options "shall remain outstanding and eligible to vest." That the certified options remain subject to time-based vesting, twenty percent a year from 12 June 2026, is stated in the annual proxy. That a termination other than for cause waives the service condition, and that a termination for cause forfeits vested and unvested options alike, is per paragraph 6(d)(ii) of the employment agreement. The excise tax agreement provides that if the merger agreement terminates it "will terminate and be of no force or effect." No filing states expressly that the compensation committee has certified the Paramount agreement as a qualifying agreement; that it satisfies the definition is this newsletter's reading. The merger proxy does not mention the November amendment. The sale of 4,004,149 shares for about $113 million on 3 March 2026, four days after the merger agreement was signed, is per the Form 4 filed under accession 0001318285-26-000009; those shares came from previously settled performance units rather than from the June 2025 options, whose first instalment vested on 12 June 2026. Zaslav's age is taken from his reported date of birth in January 1960, making him seventy in the final year of the extended term. The observation that succession pressure ordinarily rises in this age range is general; on the closest evidence, Jenter and Lewellen, Journal of Finance 70(6), 2015, bid rates for firms whose chief executive has passed sixty-five run near six percent a year against four percent below that age, and premiums run eight to ten percentage points lower. The change-of-control payments disclosed for all five named executives total $1.35 billion, of which Zaslav's share is 65.5 percent, per the merger proxy.